Table 1:

Patient demographics and tumor characteristics

No.	Age, Sex	Histology				IVIM Parameters			ADC (× 10⁻³ mm²/s)
No.	Age, Sex	Pathologic Diagnosis	WHO Grade	MIB-1 (%)	MVD	D (× 10⁻³ mm²/s)	f (%)	D* (× 10⁻³ mm²/s)	ADC (× 10⁻³ mm²/s)
1	6 yr, M	Diffuse midline glioma, H3 K27M-mutant	IV	59.2	3.1	1.50	16.4	5.6	1.61
2	4 yr, M	Medulloblastoma, classic, histologically defined	IV	15.6	34.7	0.30	37.7	13.7	0.56
3	11 yr, M	Medulloblastoma, classic, histologically defined	IV	72.6	10.2	0.53	27.1	30.2	0.87
4	3 yr, M	Atypical teratoid/rhabdoid tumor	IV	50.0	11.0	0.86	14.1	9.0	0.98
5	2 yr, F	Anaplastic ependymoma	III	23.2	12.5	0.87	19.3	18.4	1.02
6	3 yr, M	Anaplastic ependymoma	III	19.6	4.3	1.15	16.8	5.5	1.30
7	6 yr, F	Anaplastic ependymoma	III	58.4	10.1	0.71	20.7	41.7	0.96
8	12 yr, M	Diffuse astrocytoma, IDH wild-type	II	2.1	2.1	1.22	8.4	33.3	1.29
9	1 yr, M	Pilocytic astrocytoma	I	4.4	5.8	1.45	3.5	5.5	1.50
10	3 yr, F	Pilocytic astrocytoma	I	6.7	4.0	1.82	7.2	10.2	1.88
11	3 yr, M	Pilocytic astrocytoma	I	8.0	4.7	1.52	10.0	48.3	1.64
12	6 yr, M	Pilocytic astrocytoma	I	6.0	3.2	1.72	4.2	58.4	1.78
13	11 yr, F	Pilocytic astrocytoma	I	4.0	5.6	1.55	5.5	12.8	1.61
14	2 yr, M	Subependymoma	I	0.1	1.9	1.58	5.1	11.3	1.60
15	2 mo, F	Choroid plexus papilloma	I	0.1	13.4	1.47	17.4	11.6	1.62
16	10 yr, M	Dysembryoplastic neuroepithelial tumor	I	2.7	1.3	1.76	10.9	4.3	1.82
17	15 yr, F	Ganglioglioma	I	1.0	1.1	1.21	3.6	22.4	1.24